We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$93.3M
Cap. Flow
-$7.51M
Cap. Flow %
-0.58%
Top 10 Hldgs %
25.17%
Holding
390
New
85
Increased
121
Reduced
146
Closed
8

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.53M
2
DOCU
DocuSign
DOCU
+$1.16M
3
AAPL icon
Apple
AAPL
+$971K
4
MZTI
The Marzetti Company
MZTI
+$858K
5
MSFT icon
Microsoft
MSFT
+$723K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.98%
2 Technology 14.73%
3 Healthcare 13.63%
4 Financials 11.39%
5 Consumer Staples 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOXA icon
251
Fox Class A
FOXA
$28.8B
$375K 0.03%
10,115
+1,448
+17% +$49.6K
DBEU icon
252
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$793M
$368K 0.03%
11,820
PRF icon
253
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
$363K 0.03%
14,315
XLV icon
254
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$363K 0.03%
3,563
+41
+1% +$3.94K
FTEC icon
255
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
$362K 0.03%
+5,000
New +$339K
IQDY icon
256
Northern Trust International Quality Dividend Dynamic ETF
IQDY
$113M
$356K 0.03%
+13,410
New +$338K
AMT icon
257
American Tower
AMT
$82.1B
$352K 0.03%
1,530
+204
+15% +$44.4K
VLO icon
258
Valero Energy
VLO
$101B
$352K 0.03%
3,764
+135
+4% +$12.8K
MSI icon
259
Motorola Solutions
MSI
$80.4B
$338K 0.03%
2,096
-97
-4% -$16K
VFC icon
260
VF Corp
VFC
$5.37B
$330K 0.03%
3,316
+798
+32% +$71.5K
CDK
261
DELISTED
CDK Global, Inc.
CDK
$328K 0.03%
5,993
-98
-2% -$5.04K
BABA icon
262
Alibaba
BABA
$296B
$327K 0.03%
1,542
-158
-9% -$29.6K
VIG icon
263
Vanguard Dividend Appreciation ETF
VIG
$113B
$326K 0.03%
2,613
+665
+34% +$80.5K
FDIS icon
264
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.7B
$325K 0.02%
+6,737
New +$314K
IWS icon
265
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$324K 0.02%
3,415
VXUS icon
266
Vanguard Total International Stock ETF
VXUS
$163B
$312K 0.02%
5,608
+239
+4% +$12.8K
IVE icon
267
iShares S&P 500 Value ETF
IVE
$50.2B
$305K 0.02%
2,345
-70
-3% -$8.71K
DLS icon
268
WisdomTree International SmallCap Dividend Fund
DLS
$1.09B
$304K 0.02%
4,281
AGG icon
269
iShares Core US Aggregate Bond ETF
AGG
$138B
$299K 0.02%
+2,664
New +$300K
ADSK icon
270
Autodesk
ADSK
$55B
$296K 0.02%
+1,612
New +$261K
IYC icon
271
iShares US Consumer Discretionary ETF
IYC
$1.2B
$290K 0.02%
5,080
-80
-2% -$4.44K
SNAP icon
272
Snap
SNAP
$9.18B
$285K 0.02%
17,480
+3,146
+22% +$46.3K
BIO icon
273
Bio-Rad Laboratories Class A
BIO
$10.4B
$280K 0.02%
756
-50
-6% -$17.6K
NOW icon
274
ServiceNow
NOW
$150B
$278K 0.02%
4,925
SU icon
275
Suncor Energy
SU
$76.5B
$261K 0.02%
7,965
-260
-3% -$8.12K

Similar funds

Dowling & Yahnke's Q4 2019 Portfolio in Review

As of Q4 2019, Dowling & Yahnke held 390 positions worth $1.3B, up 7.7% from $1.21B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dowling & Yahnke's Q4 2019 filing shows 85 new, 121 increased, 146 reduced and 8 closed positions. Its largest new stake was iShares National Muni Bond ETF: 4,701 shares worth $535K. The largest sale was Celgene Corp, an estimated $2.53M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q4 2019 buy was iShares National Muni Bond ETF: 4,701 shares worth $535K.
  • Dowling & Yahnke added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.6M increase.
  • Dowling & Yahnke's biggest Q4 2019 reduction was DocuSign, cutting an estimated $1.16M.
  • Dowling & Yahnke fully exited Celgene Corp in Q4 2019, selling an estimated $2.53M.
  • Dowling & Yahnke's ten largest holdings make up 25% of its $1.3B portfolio in Q4 2019.
  • Dowling & Yahnke opened 85 new positions and closed 8 in Q4 2019.
  • Dowling & Yahnke's portfolio value rose 7.7% quarter-over-quarter to $1.3B.

Based on Dowling & Yahnke's 13F filing for Q4 2019, filed 27 Jan 2020.